S6K1 genetic inactivation reduced tumor progression in PTEN-deficient leukemia and PTEN-deficient pheochromocytoma, as well as in a model of acute myeloid leukemia (17, 22, 23). This evidence concerns the gene PTEN and acute myeloid leukemia.